Latest CancerVax Stories

2010-09-28 05:28:00

DALLAS, September 28, 2010 /PRNewswire/ -- ReportsandReports announces it will carry Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/33665-emerging-cancer-vaccines- forecasts-developments-and-pipeline-an.html Search More Than 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All Kalorama...

2010-09-20 06:59:00

NESS ZIONA, Israel, September 20, 2010 /PRNewswire-FirstCall/ -- NasVax (TASE: NSVX) announces that it has initiated recruitment and dosing in a Phase 2a clinical trial for oral anti-CD3 (aCD3) monoclonal antibody (MAb) immunotherapy.

2010-06-29 07:30:00

BETHESDA, Md., June 29 /PRNewswire-FirstCall/ -- Micromet, Inc.

2010-06-15 15:47:07

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma.

Word of the Day
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.